The Real Reason Chinese Companies Behave Differently Oversea | Digging into China
A viral Chinese internet joke—“Western medicine works fast”—has evolved into a sharp commentary on corporate behavior and regulation. The phrase describes how quickly Chinese companies change their practices when confronted with strong European enforcement. From automotive repair and diagnostic access to e-commerce, pricing, product safety, and consumer protection, companies that may resist or neglect domestic demands often comply rapidly when market access and enormous financial penalties are at stake.
The deeper lesson is not that Chinese companies lack the technology or ability to meet higher standards. It is that corporate behavior responds to incentives. When the cost of breaking rules is low, non-compliance can become economically rational. When regulators impose meaningful penalties or threaten market access, compliance suddenly becomes a priority.
For Chinese consumers, this has created an uncomfortable realization: the problem may not be capability, but enforcement—and the incentives created by the regulatory system.
🙏 This channel runs on coffee and stubbornness. If you'd like to help it grow, a small donation goes a long way: https://paypal.me/DonXiang
The phrase \"Western medicine acts fast\" describes how strict EU regulations force Chinese companies to resolve consumer grievances they previously ignored. This phenomenon reveals that corporate misconduct is often a calculated cost-benefit choice rather than a lack of capability, as companies prioritize compliance only when market access and heavy fines are at stake.
Hi, I'm Dong Xiong. Welcome to Digging into China, where we take a deep dive into what's
really happening in China and share some unique insights. The fast-acting effect of western
medicine. It sounds like the punchline to a medical joke, the kind of dry humor you might
hear in a clinic waiting room. But across Chinese internet recently, it has become something very
different, a viral piece of social commentary, a biting economic observation, and a profound
reflection on governance, globalization, and corporate behavior. When people online started
repeating the phrase, western medicine acts fast, they were not talking about the pharmaceuticals,
traditional herbs, or medical treatments. They were talking about the European Union.
More specifically, they were talking about what happens when European regulatory authorities
step into the room, lay down the law, impose enormous fines, and force major Chinese corporations
from electric vehicle makers to cross-border e-commerce giants to clean up their act in a
matter of weeks. Practices that Chinese consumers had complained about for years,
issues that domestic regulators seemed unable or unwilling to curb, were suddenly resolved with
surgical precision the moment these companies tried to sell their products in Brussels, Paris,
or Berlin. The contrast was too stark to ignore, and the irony was too heavy to miss. For decades,
the Chinese public narrative around foreign trade regulations was one of defensive nationalism.
Whenever a western bloc imposed new standards, inspection protocols, or trade restrictions on
domestic exports, the immediate public reaction was often outrage. It was viewed as protectionism,
a deliberate attempt to stifle rising industries, or a geopolitical maneuver designed to keep
Chinese competitors down. But this time, something fundamental shifted. When the European Union
enforced strict rules governing access to vehicle repair and maintenance information,
requiring manufacturers to provide independent operators with standardized, non-discriminatory
access to diagnostic information, repair data, and other technical resources, the reaction back
home was not anger. It was applause. Chinese people looked at European rules,
looked at how quickly Chinese car companies scrambled to translate their technical manuals
into multiple languages and provided the required information and access, and said,
look at that, western medicine really does act fast. To understand why this phrase resonated
so deeply, you have to look at the underlying frustration that birthed it. For years,
domestic consumers have lived with a peculiar, double-standard reality in manufacturing and
services. It is a reality where a single factory operating in the exact same industrial park,
with the exact same workforce, can produce two completely different tiers of quality,
based entirely on where the final box is being shipped. Consider the famous food safety scandal
from a few years ago involving pickled vegetables, a staple ingredient in popular
instant noodles. When investigative reporters went undercover, they filmed local suppliers
curing vegetables in open dirt pits, with workers walking over the produce in dirty footwear,
tossing cigarette butts directly into the curing vats. It was a stomach-turning revelation that
outraged millions. But the most revealing part of that exposé was not the filth of the domestic
pit, it was the managers' candid admission about their export line. Right next door to the dirt
pit, the exact same facility maintained a high-tech, automated processing plant for export orders
bound for Japan. On that line, the pickled vegetables were cured in sanitized, climate-controlled
tanks. They were washed multiple times before packaging. Before leaving the factory floor,
every container passed through an industrial x-ray machine to detect foreign contaminants.
When asked on camera why the factory maintained such a night-and-day difference,
the plant manager was brutally honest. If domestic regulators caught a containment in a batch sold
at home, the fine was a few thousand yuan, a minor inconvenience, a rounding error on the
balance sheet. But if a Japanese importer detected a foreign object, the financial penalties could
reach hundreds of thousands of dollars, accompanied by immediate shipment rejections and potential
blacklisting. It was never a question of capability. The factory had the technology,
the equipment, and the operational knowledge to produce food clean enough to pass an x-ray
inspection every single day. They chose not to do it for domestic consumers because the regulatory
stick at home was too thin, while the regulatory stick abroad was heavy enough to destroy their
business. Capability was never the constraint. Incentive was. This brings us to the core
mechanism driving the Western medicine phenomenon, the cold, rational calculus of
corporate cost-benefit analysis. Businesses are not moral entities. They are economic engines
designed to maximize return on capital while minimizing friction and operational costs.
When a company calculates its operational strategy, it measures the cost of compliance
against the cost of non-compliance. In a regulatory environment where enforcement is sporadic,
where legal proceedings drag on for years, and where statutory fines are capped at nominal
amounts, non-compliance becomes a rational business strategy. If breaking a rule earns
a company $10 million in profit and the statistical probability of getting caught
multiplied by the eventual fine equals $50,000, then any rational corporate abroad will choose
to break the rule every day of the week. In that environment, the fines are not a deterrent.
They are simply lying under operating expenses, the price of doing business. This mathematical
reality explains the entrenched abuses in the domestic automotive retail ecosystem. For years,
car owners have suffered under the oppressive practices of franchised dealership networks.
If you buy a vehicle, you are quickly trapped in an ecosystem designed to extract maximum value
from after-sales maintenance. If a minor sensor breaks or a plastic bracket snaps,
independent mechanics may be legally or technically restricted from fixing it. The manufacturer may
refuse to provide original spare parts to third-party garages. If you dare to buy an
aftermarket part that is physically identical to the original and costs a third of the price,
the dealership may threaten to void or limit warranty coverage. Even worse is the technological
lock-in. Modern automobiles are no longer just mechanical assemblies of gears, pistons,
and physical linkage. They are rolling supercomputers governed by proprietary software
modules, localized networks, and complex electronic control units. To diagnose a problem,
clear a fault code, or calibrate a newly installed component, a mechanic needs access to the vehicle's
on-board diagnostic interface, diagnostic software, and in some cases, proprietary software
security systems. For years, manufacturers have restricted access to these digital systems.
They often limit software access to authorized dealership networks, leaving independent repair
shops with far less information and fewer tools. Independent mechanics may be unable to read
certain error codes, update firmware, or reset vehicle systems without manufacturer-controlled
equipment or software. In some cases, attempts to circumvent the digital security system can also
raise legal issues under computer access or anti-circumvention laws. Why do dealerships
and automakers guard this ecosystem so fiercely? The answer lies in the distorted economics of
the automotive industry. In recent years, intense price wars have pushed new car sales margins
into negative territory for some dealerships. To survive, many franchised dealers have relied
heavily on after-sales service, repairs, and parts markups to generate profit. The new car
can effectively become a loss leader used to lock the customer into an expensive multi-year repair
ecosystem. Furthermore, massive dealership networks serve an important financial function for auto
manufacturers. They can act as capital shock absorbers. When factory assembly lines produce
more vehicles than the organic market can absorb, manufacturers may encourage dealerships to take
on additional inventory, increasing their debt burden while helping keep factory production
moving. Because dealerships carry this financial burden and depend heavily on manufacturers
whose brands they represent, they possess significant economic incentives to preserve
profitable after-sales ecosystems. Now, enter the European Union. When European lawmakers looked at
the automotive sector, they did not approach it simply from the perspective of protecting
manufacturer balance sheets or preserving dealership networks. They approached it from
the perspective of competition, consumer rights, and the functioning of the internal market.
Europe also has a long-established ecosystem of independent auto repair shops and after-market
parts suppliers. To protect competition in this ecosystem, the European Union established rules
governing vehicle type approval and market surveillance. Under EU Regulation 2018-858,
vehicle manufacturers are required to provide independent operators, including third-party
repair shops, parts distributors, and diagnostic equipment manufacturers with standardized and
non-discriminatory access to vehicle repair and maintenance information, including relevant
on-board diagnostic information, diagnostic equipment, software, and technical documentation.
The key phrase in that legislation is non-discriminatory. Manufacturers cannot simply
reserve essential repair and maintenance information for their authorized networks
while arbitrarily denying equivalent access to independent operators. The rules are designed
to ensure that independent operators can compete effectively in the repair and maintenance market,
subject to the applicable conditions and reasonable, proportionate fees for certain
information and services. This is where the European system changes the corporate calculation.
Vehicle type approval is the fundamental regulatory authorization through which
a vehicle model can be certified for the European market. Under Regulation 2018-858,
authorities have significant enforcement powers when manufacturers fail to comply with their
obligations. Depending on the circumstances and the seriousness of the violation,
enforcement measures can include corrective actions, fines, suspension, or withdrawal of
type approval. That distinction is important. Non-compliance does not automatically mean that
an automaker instantly loses its type approval. But the possibility of losing or having approval
suspended gives regulators a powerful lever because type approval is directly connected
to market access. A fine can be calculated, budgeted, and potentially passed on to consumers,
but the possibility of losing access to a major market is an entirely different economic threat.
When faced with the choice between providing legally required access to repair and diagnostic
information, or risking serious regulatory consequences, global automakers, including
rising electric vehicle exporters, have a powerful incentive to comply. They do not necessarily need
to launch public relations campaigns complaining about unfair treatment. They need to meet the
regulatory requirements if they want continued access to the market. And that is precisely where
the Western medicine metaphor comes from. Requirements that might have been difficult
or slow to enforce domestically can become immediate corporate priorities
when access to a major international market depends on compliance.
A similar transformation is unfolding across the digital company and global e-commerce.
For years, online shoppers have navigated a digital landscape littered with manipulative
design tactics known as dark patterns. These are user interface designs specifically engineered
to trick, coerce, or manipulate consumers into making choices that benefit the platform
at their own expense. We see these tactics every day. There is the fake sense of urgency,
flashing banners proclaiming only three items left in stock, or sales end in 12 minutes,
when in reality the inventory is endless and the timer simply resets every time you refresh the
page. There is deceptive pricing, striking through an artificially inflated original price that was
never actually charged, making a completely ordinary price look like a 50% discount.
There is the subscription trap, allowing a user to sign up for a paid service with a single click
in two seconds, but hiding the cancellation option deep inside a five-tier submenu behind
obscure settings, pages, and grayed-out confirmation text. And there is coercive data collection,
refusing to let users view a product or use a basic service unless they hand over their
personal phone numbers, contacts, and location data. In addition to dark patterns, corporate
greenwashing became rampant. Platforms routinely marketed products with sweeping,
unverified environmental claims, using terms like ego-friendly, carbon-neutral,
or sustainable on mass-produced items without providing a shred of scientific evidence or
supply chain transparency to back those claims up. When operating under domestic regulations
where consumer protection enforcement was historically fragmented, these platforms
turned deceptive practice into fine-tuned algorithmic science. But as these cross-border
platforms expanded aggressively into foreign markets, shipping hundreds of millions of
packages directly to international consumers, they ran head-first into European regulatory
frameworks like the Digital Service Act and strict consumer protection authorities.
European regulators did not view manipulative UI design or fake discounts as clever marketing.
They viewed them as unlawful consumer deception and systemic market distortion. And once again,
the regulatory stick they brought to the table was massive. When fast fashion and e-commerce
platforms engaged in deceptive pricing, unverified greenwashing, or failed to curb
the listing of non-compliant products, European authorities did not issue token penalties.
France's regulatory watchdog hit major fast fashion platforms with tens of millions of
euros in fines for fake discounts and misleading environmental claims, with penalties rapidly
accumulating across different enforcement actions. When major cross-border e-commerce
platforms submitted genetic copy-pasted risk assessment reports rather than conducting
rigorous audits of products safely, leading to situations where imported plastic toys
were found to contain toxic chemical plasticizers hundreds of times above legal safety limits,
European regulators did not engage in diplomatic, polite nudging. They launched formal
non-compliance proceedings backed by the full weight of the Digital Service Act.
The climax of this regulatory enforcement came when European authorities issued massive fines
against major global platforms for failing in their legal duty of diligence. In one landmark
enforcement action under the Digital Service Act, Aliexpress was hit with a staggering
550 million euro fine, equal to billions of local currency units. The core legal ground
was not simply that illegal or counterfeit goods were found on the platform, but that the platform
failed to maintain adequate, proactive mechanisms to assess and mitigate the risk of illegal goods
being listed in the first place. The European regulator responsible for the enforcement
summarized the philosophy behind the fine in a single, uncompromising statement.
Scale is not an excuse. If your volume of goods is so large that you claim you cannot manage
compliance, then that does not give you the right to sell unsafe or illegal products. You simply
do not sell them. That single statement encapsulates the profound operational divide
between different regulatory philosophies. It rejects the narrative that rapid corporate growth,
algorithmic complexity, or supply chain scale grants a company immunity from basic consumer
safety laws. It asserts that compliance is not an optional feature to be added if convenient,
but the foundational price of market entry. When these multi-hundred million euro fines landed,
the corporate response was immediate. Platforms facing serious regulatory pressure had to
strengthen their compliance system, review their user interface, improve pricing practice,
and tighten oversight of supplies and listings. Once again, the public watched these regulatory
interventions from afar and marveled at the speed of the cure. So why has the public reaction to
these regulatory crackdowns evolved from historical indignation to widespread appreciation? Why are
consumers back home openly celebrating foreign regulatory bodies for finding their own Chinese
corporate giants? The first reason is simple, empathetic envy. When everyday citizens see
European consumers enjoy open repair rights, transparent pricing, accessible spare parts,
strict product safety standards, and real data privacy protections, they do not see an ideological
battle. They see a higher standard of living. They see a marketplace where the individual
consumers' dignity and rights are protected against the overwhelming leverage of corporate
conglomerates. They look at those protections, look back at their own daily interactions with
monopolistic dealerships, dark UI patterns, and unhelpful customer support lines,
and naturally ask, why can't we have that here? The celebration of Western medicine is not an
endorsement of foreign geopolitical agenda. It is a desperate, heartfelt plea for stronger
domestic consumer protections. Consumers want the exact same high-quality products,
the exact same transparent service, and the exact same legal protections that Chinese factories
and platforms are already providing they can deliver when forced to do so abroad.
The second reason is rooted in a pragmatic understanding of global economics and employment.
In an era of economic uncertainty, industrial overcapacity, and soft domestic consumer demand,
export markets are no longer just a growth avenue, they are a vital economic lifeline.
Factories, supply chains, and millions of manufacturing jobs depend directly on
maintaining access to international consumer markets. If major export industries, whether
electric vehicles, consumer electronics, or cross-border e-commerce, get banned or restricted
in foreign markets because they refuse to adhere to international standards of safety,
fair competition, and repair access, the economic fallout back home would be catastrophic.
Production lines would stall, factories would close, and workers would lose their livelihoods.
Consumers understand this reality clearly. They know that corporate giants must adapt to
international rules not only to protect consumers, but to preserve the national manufacturing base
itself. Compliance is no longer optional. It is a requirement for industrial survival.
The third and most profound reason is a growing national consensus on the urgent
need to upgrade domestic consumption. For years, economic planners have sought ways to transition
the economy away from over-reliance on infrastructure investment and real estate
development towards a sustainable, consumption-driven model. But you cannot build a
vibrant, sustainable consumer economy on a foundation of consumer distrust. When consumers
feel that buying a car means trapping themselves in a predatory repair monopoly,
when they feel that shopping online means navigating a minefield of dark patterns and
fake discounts, and when they feel that food safety depends on whether a product was intended
for export or local distribution, they naturally pull back. They hold onto their savings, reduce
spending, and approach the marketplace with deep suspicion. Deceptive corporate practices
actively destroy consumer confidence, draining the economic vitality out of the domestic market.
By watching how European regulations force corporations to eliminate dark patterns,
open repair ecosystems, and elevate product safety, people recognize a clear roadmap for
domestic reform. They realize that protecting consumer rights is not an economic burden that
hinders corporate growth, but the essential prerequisite for building a mature, trustworthy,
and high-value consumer market. Ultimately, the meme, Western medicine acts fast,
is a powerful metaphor for the evolution of corporate governance in a globalized world.
It exposes the flaw in treating corporate compliance as an abstract, voluntary ideal.
Corporations do not reform because they undergo a moral awakening. They reform when the institutional
framework leaves them no other choices. The ultimate goal, of course, is not to rely
indefinitely on foreign regulators to police domestic industries. The true hope embedded
within this viral commentary is that domestic regulatory frameworks will absorb the lesson,
upgrade their enforcement mechanisms, and apply the same decisive principles at home.
When statutory fines are increased from token amounts to meaningful percentage of global
revenue, when pre-market access gatekeeping is applied rigorously to protect consumer safety
and fair competition, and when the legal system eliminates the calculated profitability of
non-compliance, domestic markets will no longer need external intervention.
Until that day comes, as long as companies continue to demonstrate that they can produce
world-class, fully compliant, user-friendly products the moment they cross the international
border, consumers will continue to point at the rapid transformations happening overseas,
smile knowingly, and remind everyone that when the regulatory medicine is strong enough,
the cure happens fast. Thank you so much for watching. If this video was helpful, please
like, subscribe, and if you are watching on your phone, click hype right below. It pushes this
video onto the trending hype leaderboard so many people can find the channel. I'll
be back with more content soon. Until then, be well.